INVESTOR AB Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0000889232

What is a 13F filing? Who files one and when · What 13F filings can't tell you

LargeFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 · 7 positions · Total reported value $14.40B · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 45.5% · 1 new · 0 cut · 4 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): -4.9% · vs SPY -19.8% · Prev Value $15.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, INVESTOR AB disclosed 7 equity positions with a combined reported value of $14.40B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Large / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were AZN ($9.78B), NDAQ ($4.61B), MDWD ($12.82M). By sector, the heaviest allocations are Health Care 68.0%, Financials 32.0%. Versus the prior quarter, allocation shifted toward Health Care (+0.6pp) and away from Financials (-0.6pp).

Versus the prior quarter, INVESTOR AB opened 1 new positions, trimmed 0 and fully exited 4, a turnover rate of 45.5% of positions. The portfolio's overlap with the prior quarter was 55% of names.

The largest new positions opened in Q2 2026 were MU ($542.52K).

Of the 4 positions fully exited versus the prior quarter, the largest were COHR ($714.63K), KYIV ($601.15K), CRSR ($553.40K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • MU MICRON TECHNOLOGY INC · $542.52K

Fully Exited (vs previous quarter)

  • COHR COHERENT CORP · prev qtr: $714.63K
  • KYIV KYIVSTAR GROUP LTD ORD · prev qtr: $601.15K
  • CRSR CORSAIR GAMING INC · prev qtr: $553.40K
  • WHR WHIRLPOOL CORP · prev qtr: $253.42K

Insider Transactions (Form 4)

Latest INVESTOR AB buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-06-11 Buy NASDAQ, INC. 56,782 $85.98 SEC filing

All insider transactions →

Fund Profile

Investor AB is an SEC-registered 13F filer. As of Q2 2026 it reported 7 US equity positions with a combined value of $14.40B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 7 positions · $14.40B reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: AZN (ASTRAZENECA PLC) at 67.9%
  • Average position size: $2.06B

Sector Tilt

  • Health Care 68.0%
  • Financials 32.0%
  • Information Technology 0.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new, 1 added, 4 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to maintain a conservative stance with a preference for stable, well-established companies in the healthcare and financial sectors. There is no clear indication of a directional market view beyond the sectors in which it invests. 2. Key Moves: - Added: Micron Technology (MU) was added as a new position, indicating a potential interest in technology, though the stake is very small. - Reduced: No positions were reduced significantly. - Increased: No holdings were increased in a material way. - Added: A small position in Cellebrite (CLBT) was added, suggesting an interest in technology companies. 3. Portfolio Structure: - Passive/Active: The portfolio appears to be more passive, with a focus on holding positions without significant changes. - Sector Bias: The fund has a strong bias towards healthcare and financials, reflecting a preference for stability and growth in these sectors. - Risk Appetite: The risk appetite seems low, as indicated by the lack of significant changes in positions and the preference for stable, well-known companies. 4. Per-Holding One-Liner: - AZN (AstraZeneca PLC): A large pharmaceutical company with a focus on biopharmaceuticals and vaccines. - NDAQ (NASDAQ INC): A financial services company that operates the NASDAQ stock exchange. - MDWD (MEDIWOUND LTD): A biotechnology company focused on regenerative medicine. - CLBT (CELLEBRITE DI LTD): A technology company specializing in data privacy and data recovery solutions. - MU (MICRON TECHNOLOGY INC): A leading manufacturer of memory and storage solutions. - VZ (VERIZON COMMUNICATIONS INC): A telecommunications company offering wireless, broadband, and internet services. - BMRN (BIOMARIN PHARMACEUTICAL INC): A biotechnology company focusing on developing therapies for rare genetic diseases. 5. One-Sentence Style Summary: The fund maintained a conservative, passive approach, focusing on stable healthcare and financial holdings, with a minor addition in technology to diversify its portfolio slightly.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 68.0%
Financials 32.0%
Technology 0.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 51.59M $9.78B 67.92%
67.92%
Hold
2 58.44M $4.61B 31.98%
31.98%
Hold
3 872.09K $12.82M 0.09%
0.09%
Hold
4 75.00K $1.09M 0.01%
0.01%
Add
5 470 $542.52K 0.00%
0.00%
New
6 11.30K $478.44K 0.00%
0.00%
Hold
7 3.70K $211.71K 0.00%
0.00%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 60% R 86% F1 71% (modelled on 2026-Q1; 6/10 hit)

Low-confidence forecast This fund replaces about 26% of its Top-10 each quarter and backtests at F1 75% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 75% · recall 77% · F1 75% · avg rank error 2.7 · Top-10 turnover 26%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 80% 80% 80% NDAQ · MU · AMZN · SWK · CCL · AMAT · ANET · CGNX · CHKP · AGRX NDAQ · MU · AMAT · ONTO · CHKP · ANET · CCL · COHR · CGNX · AGRX
2024-Q2 60% 100% 75% NDAQ · MU · AMAT · ANET · CHKP · ONTO · CCL · CGNX · COHR · AGRX NDAQ · ONTO · CHKP · CCL · COHR · CGNX
2024-Q3 100% 86% 92% NDAQ · CHKP · ONTO · CCL · CGNX · COHR NDAQ · MDWD · CHKP · ONTO · COHR · CCL · CGNX
2024-Q4 71% 62% 67% NDAQ · MDWD · CHKP · ONTO · CCL · COHR · CGNX NDAQ · MDWD · CHKP · CLBT · CCL · COHR · BLK · MCHP
2025-Q1 100% 80% 89% NDAQ · MDWD · CHKP · CCL · CLBT · COHR · MCHP · BLK NDAQ · MDWD · TIGO · CDNS · MCHP · CHKP · CLBT · COHR · BLK · CCL
2025-Q2 90% 90% 90% NDAQ · MDWD · TIGO · CHKP · MCHP · CDNS · CCL · COHR · BLK · CLBT NDAQ · MDWD · MCHP · TIGO · CDNS · CHKP · CLBT · CCL · COHR · TER
2025-Q3 70% 70% 70% NDAQ · MDWD · MCHP · TIGO · CCL · CHKP · COHR · CLBT · CDNS · WHR NDAQ · MDWD · MCHP · TER · CHKP · CLBT · CCL · ORCL · KYIV · WHR
2025-Q4 60% 60% 60% NDAQ · MDWD · MCHP · TER · CHKP · CCL · CLBT · WHR · ORCL · KYIV NDAQ · MDWD · COF · COHR · CLBT · CHKP · CRSR · CCL · QBTS · WHR
2026-Q1 60% 60% 60% NDAQ · MDWD · COHR · CHKP · CLBT · COF · CCL · QBTS · CRSR · BMRN AZN · NDAQ · MDWD · CLBT · COHR · KYIV · VZ · CRSR · WHR · BMRN
2026-Q2 ★ 60% 86% 71% AZN · NDAQ · MDWD · CLBT · COHR · BMRN · WHR · KYIV · CRSR · VZ AZN · NDAQ · MDWD · CLBT · MU · VZ · BMRN

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did INVESTOR AB buy in 2026-Q2?

In its 2026-Q2 13F filing, INVESTOR AB reported 7 equity positions worth $14.40B in aggregate; its largest disclosed positions were AZN ($9.78B), NDAQ ($4.61B), MDWD ($12.82M).

How large is INVESTOR AB's portfolio?

INVESTOR AB reported $14.40B of long equity holdings across 7 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is INVESTOR AB's investment style?

HoldingsHub classifies the portfolio as Large / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/investor-ab/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →